| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.58B | 48.11B | 44.47B | 45.58B | 45.47B | 49.67B |
| Gross Profit | 18.19B | 17.93B | 16.41B | 16.95B | 17.80B | 21.32B |
| EBITDA | 5.96B | 5.24B | 3.23B | 4.12B | 3.00B | 5.14B |
| Net Income | 3.66B | 2.83B | 1.27B | 1.83B | 1.11B | 2.53B |
Balance Sheet | ||||||
| Total Assets | 45.01B | 47.54B | 45.81B | 47.11B | 44.40B | 46.82B |
| Cash, Cash Equivalents and Short-Term Investments | 9.07B | 10.11B | 13.77B | 14.18B | 11.93B | 11.97B |
| Total Debt | 522.00M | 695.00M | 593.00M | 638.00M | 735.23M | 611.02M |
| Total Liabilities | 11.86B | 14.30B | 12.01B | 14.14B | 12.55B | 14.18B |
| Stockholders Equity | 32.50B | 32.57B | 33.16B | 32.39B | 31.27B | 32.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.60B | 801.00M | 3.22B | 907.16M | 3.27B |
| Operating Cash Flow | 0.00 | 3.29B | 1.64B | 4.36B | 2.67B | 4.42B |
| Investing Cash Flow | 0.00 | -4.79B | -981.00M | -1.24B | -1.67B | -1.56B |
| Financing Cash Flow | 0.00 | -2.42B | -1.16B | -983.00M | -1.08B | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥154.90B | 29.58 | ― | 5.00% | 1.41% | 0.75% | |
71 Outperform | ¥88.32B | 11.16 | 7.23% | 3.53% | 3.05% | -32.61% | |
66 Neutral | ¥31.01B | 53.05 | ― | 2.84% | 5.30% | 4.62% | |
66 Neutral | ¥34.76B | 6.92 | ― | 1.81% | 0.22% | 4.15% | |
64 Neutral | ¥21.24B | 33.88 | ― | 0.91% | 13.12% | 27.53% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
48 Neutral | ¥40.11B | -33.63 | ― | 1.23% | -14.80% | 89.50% |